02:59 AM EDT, 07/14/2026 (MT Newswires) -- BioPharma Credit (BPCP.L, BPCR.L) and affiliate BioPharma Credit Investments V (Master) provided a $400 million financing to Archimed to fund its acquisition of Esperion Therapeutics. The British life sciences debt investment trust's allocation under the commitment was $120 million, according to a Tuesday filing.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.